PLUR MEXC RealStocks
Own real PLUR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:33:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Pluri Inc. (PLUR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.95, with a market capitalization of $14.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.85 to $4.12. This page covers its latest market performance, valuation, price trends and company information.
$14.95M | |
$0.99 | |
$1.04 | |
$0.91 | |
$0.98 | |
34.97K | |
36.81K | |
-- | |
$4.12 | |
$0.85 | |
-- | |
2026-09-30 |
Pluri Inc. (PLUR) last closed at $0.95 as of 2026-11-18 22:32:00, down 3.96% ($0.04) from the previous close of $0.98.
During the latest regular trading session, PLUR traded between $0.91 and $1.04, with a volume of 34.97K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Pluri Inc. (PLUR) moved from $1.18 to $0.95, representing a decline of 19.83% ($0.23).
The stock traded between $0.91 and $1.26 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 24.42 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.9%
PLUR is currently trading at $0.95, placing it 2.9% of the way from its 52-week low of $0.85 to its 52-week high of $4.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 113 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pluri Inc. (PLUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PLUR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PLUR shares and USD.
PLUR Shares to USD
1.00 PLUR shares = 0.946 USD
Calculations are estimates based on the latest available price and are for reference only.